x
French biotech Ciloa outlines how 14 years of exosome engineering trials led to breakthrough adiponectin biotherapeutic now advancing toward Phase I trials in 2027. CEO
Paris biotech One Biosciences outlines how single-cell transcriptomics can transform precision oncology by capturing the cellular complexity that traditional bulk sequencing misses. Founded by Institut
Irish biotech Priothera is advancing mocravimod, a non-immunosuppressive S1P receptor modulator that the founding team rescued from Novartis’ pipeline, now targeting improved survival outcomes for
Swedish biotech Alligator Bioscience outlines how strategic antibody engineering and focused execution positioned mitazalimab for pivotal trials in metastatic pancreatic cancer, transforming from university research
Addressing an Aggressive Pediatric Disease with No Treatment Options Spanish biotech Minoryx has carved out a critical position in orphan CNS diseases by developing leriglitazone
“When you are seeing great results in your research lab, you think that everything has been done. But then when you try to humanise your
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
